Injectable 'Mini Livers' Successfully Integrate into the Body, Say MIT Scientists

Breakthrough in Mini Liver Development

According to НВ — Техно: July 2, 08:30. Researchers at the Massachusetts Institute of Technology have engineered injectable tissue implants dubbed 'mini livers.' In experiments conducted on mice, these implants successfully integrated into the body for at least two months and performed essential liver functions. This innovation could significantly reshape the future of liver disease treatment.

The technology relies on a combination of liver cells and tiny hydrogel beads containing fibroblast cells. The 'mini livers' are administered under ultrasound guidance, ensuring both precision and safety. The implants were delivered into the abdominal fat tissue, where they were able to take hold and carry out their critical biological roles.

Study Findings and Future Potential

The experiment ran for eight weeks, during which the behavior of the implants inside the mice was closely monitored. However, the method currently requires the use of immunosuppressants, a key consideration for future research.

Sangeeta Bhatia, one of the lead researchers, described these implants as 'a kind of satellite liver.'

The development of 'mini livers' presents a novel strategy for tackling liver diseases, which rank among the most prevalent health issues worldwide. Given the limited availability of organ transplants and the long waiting lists for donor livers, these implants could offer an alternative for patients in urgent need of treatment. Subsequent phases of research may include:

• Refining the technology to reduce the reliance on immunosuppressants
• Enhancing the safety and effectiveness of these implants for clinical use